Synairgen PLC operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Synairgen PLC with three other
companies in this sector in UNITED KINGDOM :
Immupharma PLC
(2018
sales of £81,281.00 [US$106,110.72 ]
of which 100%
was Pharmaceutical Research & Development),
Diurnal Group PLC
(£73,000.00 [US$95,300.04 ]
of which 100%
was Alkindi), and
Redx Pharma PLC
(£129,000.00 [US$168,406.92 ]
of which 100%
was pharmaceutical).
Sales Analysis.